BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22152567)

  • 21. Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy.
    Hensiek AE; Kellerman AJ; Hill JT
    Br J Neurosurg; 2000 Aug; 14(4):354-6. PubMed ID: 11045205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid receptors in endolymphatic stromal myosis.
    Baker VV; Walton LA; Fowler WC; Currie JL
    Obstet Gynecol; 1984 Mar; 63(3 Suppl):72S-74S. PubMed ID: 6700885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical adrenal insufficiency in patients receiving megestrol therapy.
    Subramanian S; Goker H; Kanji A; Sweeney H
    Arch Intern Med; 1997 May; 157(9):1008-11. PubMed ID: 9140272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
    Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
    Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual.
    Bergoglio MT; Gómez-Balaguer M; Almonacid Folch E; Hurtado Murillo F; Hernández-Mijares A
    Endocrinol Nutr; 2013 May; 60(5):264-7. PubMed ID: 23022362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dramatic Shrinkage with Reduced Vascularization of Large Meningiomas After Cessation of Progestin Treatment.
    Kalamarides M; Peyre M
    World Neurosurg; 2017 May; 101():814.e7-814.e10. PubMed ID: 28300711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
    Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
    Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous hormone use and meningioma risk: what do we tell our patients?
    Claus EB; Black PM; Bondy ML; Calvocoressi L; Schildkraut JM; Wiemels JL; Wrensch M
    Cancer; 2007 Aug; 110(3):471-6. PubMed ID: 17580362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple basaloma and meningioma following long-term arsenic therapy].
    Weiss J
    Hautarzt; 1981 Dec; 32(12):649-50. PubMed ID: 6797987
    [No Abstract]   [Full Text] [Related]  

  • 30. Further data favouring hormonal dependency of cerebral meningiomas: evidence from a patient treated with cabergoline.
    Castelo-Branco C; Martinez MJ; Balasch J
    Gynecol Endocrinol; 2011 Feb; 27(2):134-7. PubMed ID: 20500108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningiomas in three male-to-female transgender subjects using oestrogens/progestogens and review of the literature.
    Ter Wengel PV; Martin E; Gooren L; Den Heijer M; Peerdeman SM
    Andrologia; 2016 Dec; 48(10):1130-1137. PubMed ID: 26888610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
    Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
    BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary symptomatic adrenal insufficiency induced by megestrol acetate.
    Delitala AP; Fanciulli G; Maioli M; Piga G; Delitala G
    Neth J Med; 2013 Jan; 71(1):17-21. PubMed ID: 23412818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is cyproterone acetate causing intracranial meningiomas?
    Majid Z; Kareem R
    J Pak Med Assoc; 2022 Oct; 72(10):2144. PubMed ID: 36661024
    [No Abstract]   [Full Text] [Related]  

  • 35. Meningiomas after cyproterone acetate exposure: Case reports in twin sisters.
    de Germay S; Lafaurie M; Dupuy M; de Germay B
    Therapie; 2021; 76(3):255-257. PubMed ID: 32418729
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report.
    Pozzati E; Zucchelli M; Schiavina M; Contini P; Foschini MP
    Surg Neurol; 2007 Dec; 68(6):671-674. PubMed ID: 17586005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Hormonal Contraception with Meningioma Location in Indonesian Patients.
    Malueka RG; Hartanto RA; Setyawan NH; Fauzi DNF; Damarjati KR; Rismawan A; Septianastiti MA; Wicaksono AS; Dananjoyo K; Basuki E; Asmedi A; Dwianingsih EK
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):1047-1051. PubMed ID: 35345379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastasis of carcinoma to meningioma.
    Ho KL
    Arch Pathol Lab Med; 1980 Jul; 104(7):394-5. PubMed ID: 6893130
    [No Abstract]   [Full Text] [Related]  

  • 39. [Meningioma under progestin treatment : what attitude to adopt ?].
    Cornu E; Pintiaux A; Reuter G; Kridelka F; Pétrossians P; Potorac I
    Rev Med Liege; 2023 Oct; 78(10):550-557. PubMed ID: 37830319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal therapy of gynecologic cancers.
    Durant JR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):29-33. PubMed ID: 6669987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.